Nanobiotix S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K is a report of a foreign private issuer filed by Nanobiotix S.A. for the month of March 2025. The filing, dated March 13, 2025, serves to incorporate by reference a press release issued on the same date (Exhibit 99.1). The registrant files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a conduit for a press release and does not contain embedded financial tables or statements.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. Specific operational or financial changes are detailed in the attached press release, which is not included in the provided text.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. These details are contained within the referenced press release (Exhibit 99.1).
Key Facts for Investor Verification
- Verify the content of the press release dated March 13, 2025, attached as Exhibit 99.1, as the core information is not present in the Form 6-K text itself.
- Confirm the company's status as a foreign private issuer filing under Form 20-F.
- Note that the Chief Financial Officer, Bart Van Rhijn, signed the report on behalf of the registrant.